Search results for: 'markets for infect as protein source'

10 Jul 2025  |  Global  |  Technology Research

Technologies for Preventing Hospital-Acquired Infections—Innovations and Growth Opportunities

A comprehensive look at the role of AI, automation, and digital surveillance technologies, showcasing the innovations that drives towards real-time detection and prevention strategies of hospital-acquired infections

Infographics

×

Hospital-acquired infections (HAI) occur 48 hours or more after hospital visit and were not present at the time of admission. Globally, around 136 million people are affected by HAIs every year. This increases the mortality rate and economic burden due to extended hospitalization and treatment. This report provides a comprehensive overview of vario...

This research service presents an overview of hospital-acquired infections, global scenario, key incidences and trends in Malaysia. The study is segmented based on the type of infections  blood stream, respiratory tract, urinary tract, surgical site and clinical sepsis. It provides in-depth geographical analysis of HAI incidence and trends in thes...

08 Sep 2025  |  Global  |  Market Research

Growth Opportunities in Global Protein and Peptide Therapeutics, Forecast to 2030

Cross-Therapeutic Expansion is Driving Transformational Growth Fueled by Novel Formats and Smarter Delivery

Infographics

×

The protein and peptide therapeutics industry is undergoing a profound transformation, driven by next-generation biologics, including multi-specific antibodies, antibody-drug conjugates (ADCs), and GLP-1 treatments. These advances are intensifying competition, while the patent expiries of blockbuster antibodies are accelerating the entry of biosimi...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides strategic insights into frontier innovations redefining therapeutic development, precision diagnostics, and immune modulating interventions. It showcases breakthroughs across engineered phage therapeutics, intracellular peptide platforms, advanced gene ...

This research service presents the findings on the anti-infectives market in Malawi, Mauritius and Zimbabwe. The market size and growth of the total anti-infectives market is provided at the total market level and at a country level. These give an insight into the major factors that are driving the market, as well as the main restraints that are li...

The World Protein Array Market deliverable of the Proteomics Market Service provides an in depth analysis of this emerging market. In addition to analysis at the segment level, we provide a penetration based forecast model derived from drug discovery R&D expenditures. Also included are market trends, challenges, opportunities and strategic conclu...

Research shows that environmental surfaces in healthcare settings play a crucial role in pathogen transmission, leading to healthcare-acquired infections (HAIs), which have a considerable cost burden. Outpatient settings also pose significant infection risks. In the United States, millions of patients frequent outpatient facilities such as ambulato...

29 Jun 2023  |  Global  |  Technology Research

Emerging Landscape of Targeted Protein Degradation Therapeutics

Rapid Technology Advances Bolster a Robust Therapeutic Pipeline

Infographics

×

This Frost & Sullivan research report provides an in-depth analysis of the emerging targeted protein degradation (TPD) space. TPD strategies enable treating various diseases not yet treatable via conventional approaches by attacking disease-causing proteins in a controlled manner, thus reducing the risk of side effects. It is estimated that 80%...

17 Aug 2022  |  Global  |  Technology Research

Therapeutic Advances in Amyloidosis

Research Efforts and Technology Developments through Partnerships and Collaborations will Push New Therapeutic Modalities into Treatment Regimens.

Infographics

×

Amyloidosis is a rare disease caused by the accumulation and the deposition of proteins such as immunoglobulin light-chain protein in AL amyloidosis and misfolded transthyretin (TTR) protein in ATTR amyloidosis. There are a few other types of amyloidosis as well, which are either a result of a preexisting condition or are not highly prevalent. Vari...